| 
                      
 
 ~ Mumps in Pregnancy ~   § Background:  Incidence in pregnancy 
has been estimated to be from 0.8 to 10 cases per 10000 pregnancies.  The significance of 
this disease in obstetrics rests with its effects on the fetus.   § Diagnosis:  Mainly based on 
clinical history and presentation: close contact with a person who has acquired mumps typical viral prodrome of fever, anorexia, malaise, and 
myalgia infection and swelling of the glands, which will resolve in 1 
week or less   § Maternal and fetal effects:  Maternal effects: ¶ Typically mumps is not 
appreciably more severe in pregnancy women 
  than it is in other adult women. ¶ Parotitis, usually 
bilateral. ¶ Mastitis and 
thyroiditis can occur in postpartum women, but not any more 
  frequently than nonpregnant women. ¶ Rare complications: 
aseptic meningitis, myocarditis, nephritis, or arthritis.  Embryonic/Fetal 
effects: ¶ Spontaneous abortion, 
when acquiring during first trimester ¶ There are no evidence 
of increased risks of prematurity and congenital 
  anomalies while having mumps in pregnant women. Presence of 
  maternal mumps infections is not an indication for therapeutic 
  abortion. ¶ Congenital mumps or 
postnatally-acquired perinatal mumps: rare   § Treatment and prevention:  Symptomatic 
management, such as analgesics, antipyretics, cold packs, etc.  Immunization (live 
attenuated mumps virus vaccine): ¶ Two-dose schedule for 
child ¶ Contraindications: 
  infants less than 1-year-old, pregnant women, 
  immunocompromised patients   § References: 1. Mumps in pregnancy. R. David Miller, MD, and W. David 
Hager, MD. Contemporary OB/GYN Feb. 2000: 119-123   Filename: Mumps in Pregnancy |